The following describes a device that is used in conjunction with a needle-based medication injection device (e.g. a prefilled syringe) that prevents needle stick injuries. The used needle is shielded by a cylindrical needle guard that surrounds and extends beyond the needle tip. In a preferred embodiment, before the needle is inserted into the patient, the needle guard projects forward to protect and substantially hide visibility of the needle to reduce patient anxiety.
The glass syringe and rubber stopper have for years provided an ideal drug storage closure having unique properties of impermeability to oxygen, low extractables, biocompatability, durability, etc. However, they are both formed by processes that do not lend themselves to tight geometrical tolerances. For instance, the syringe flange is formed when a glass tube is heated to a soft state and the edges pressed over to form an edge. Typical tolerances for the inside length of a syringe or the length of a stopper are both +/−0.5 mm. The finger flange thickness has a similar tolerance. Furthermore, tight tolerances were not originally needed by these devices because they were not used mechanically with other devices. Existing passive anti-needle stick safety devices for prefilled syringes must mount to the syringe but not interfere excessively with the force required to move the plunger rod during injection nor prevent the full travel of the plunger rod, which terminates when the stopper reaches the distal end of the inside of the syringe. The safety mechanism necessarily must be triggered toward the end of administration of the drug (near the end of the plunger rod travel). However, since virtually all safety devices locate the syringe against the safety device at a point under the syringe finger flange, a stack up of worst-case tolerances can put the required plunger rod travel variance at +/−1.5 mm, when considering the tolerances of the inside length of the syringe, syringe flange thickness, and stopper length (syringe manufacturers reference the syringe inside length from the proximal end of the syringe, not the distal underside of the finger flange). Accommodating the 3 mm plunger rod position variance is very difficult for safety devices and it is desirable to reduce and or eliminate any dependence of the safety device on the syringe and stopper tolerances.
The present safety device described herein is directed to a needle guard for a syringe having the safety device triggering mechanism independent of the syringe and stopper tolerances. The present device is triggered when the needle guard body is displaced proximally relative to the device as the needle is inserted into the patient. The triggering point is broadly placed between point C and an angled step-down feature proximal to point C (
The present safety device also makes locking the needle shield completely contemporaneous with needle removal from the patient, reducing the possibility of needle stick injuries when, for instance, a patient suddenly jerks or flinches causing the needle to come out of the patient unexpectedly. Most commercially available needle safety devices require the plunger rod to be fully depressed in order to activate the safety mechanism.
Other systems, methods, features and advantages of the invention will be or will become apparent to one with skill in the art upon examination of the following figures and detailed description.
The details of the invention, including fabrication, structure and operation, may be gleaned in part by study of the accompanying figures, in which like reference numerals refer to like parts. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. Moreover, all illustrations are intended to convey concepts, where relative sizes, shapes and other detailed attributes may be illustrated schematically rather than literally or precisely.
The present safety device described herein is directed to a needle guard for a syringe having the safety device triggering mechanism independent of the syringe and stopper tolerances. The fully assembled safety device 10 is shown in
As shown in
Immediately before injecting medication into a patient, the RNS 40, as depicted in
As the RNS removal tool 50 is withdrawn from the end of the device 10, the needle guard body 80 slides forward, as shown in
Prior to removal of the RNS 40, the protrusion 64 is in position A of the needle guard body grooves 90 as shown in
As the needle 24 is inserted into the patient, the patient's skin pushes the needle guard body 80 proximally against the force of the spring 61, such that the groove protrusion 90-64 interface moves from position B along the second groove section 93 to position C as shown in
After the injection is complete and the device 10 is pulled away from the patient, the needle guard body 80 moves distally, as shown in
As the needle guard body 80 moves from position C to position D as the needle 24 is pulled from the patient, it is projected distally around the needle 24 to the extent that it protects the caregiver and others from inadvertently being stuck by the needle tip 25. As shown in
For patients that have limited hand strength, holding the device against the skin while the needle 24 is in the injection site, requires maintaining a force against the spring 61 that pushes against the needle guard body 80 (position C in
The sequence of steps to operate the device is described in
A composite of 3 steps to inject medication is shown in
In
To facilitate movement of the main body 60 and its protrusions 64 with respect to the grooves 90 of the needle guard body 80, one or both components can be made using a plastic resin with ample lubrication (e.g. high content of mold release). Alternatively, dissimilar plastic resins exhibiting a low mutual coefficient of friction can be used for the components.
It is to be understood that there exist alternative arrangements of components that would still fall within the scope of what is described and claimed within this application. For instance, the needle guard body 80 could be positioned on the outside of the main body with interior-facing grooves and outwardly facing protrusions on the main body 80.
An alternative embodiment for the safety device is presented for use with light-sensitive drugs that require only minimal exposure to light. In this embodiment, the components of the device are made of opaque materials (e.g. plastic resins with pigments, tinted glass, etc.) that effectively block light from reaching the drug in the medication delivery device. However, drug injection instructions normally require the caregiver to inspect the drug to check that it is not cloudy, etc. prior to giving the injection. To achieve this, as shown in
The RNS 40, RNS removal tool 50, and plunger rod 22 components would also be made of opaque materials to prevent light exposure at the ends of the device 10. A covering (not shown) over the proximal end of the syringe with a hole for the plunger rod could also be created to provide additional light protection. Similarly, a second cover (158; see
The RNS 40 not only protects the needle 24 from being bent or its tip 25 from being damaged but it also forms one of the sterile barriers for the drug closure system. It must perform these functions before, during, and after sterilization and is therefore a complicated component that receives a tremendous amount of testing during the drug development and approval process. Since it has potential contact with the drug inside the syringe 20, it becomes part of the specific drug closure system that receives regulatory approval and is therefore difficult to change after approval. They have become industry standard devices produced by specialized third party manufacturers. Nevertheless, they have limitations and deficiencies, namely that they can become difficult to remove from the syringe 20 after sterilization and storage, often requiring greater than 20 N of force to remove. On a small part (approximately 0.25 inches in diameter, 1 inch long) such as this, it makes it difficult for healthcare workers to remove due to the small grasping area. Patients that perform self-administration, especially those with limited manual dexterity or strength (e.g. arthritic or multiple sclerosis patients) will find it extremely difficult to remove. Therefore, an added improvement of the present device 10 is to facilitate the RNS 40 removal. This is accomplished by the RNS removal tool 50, which, as shown in
The mechanical advantage of the barbs 54 engaging the edges of the retention windows 62 provides a strong radial squeeze so that the inwardly projecting capture lips 75 on the RNS removal tool 50 further engages the proximal edge 42 of the RNS 40 as shown in
Although this description has used a RNS 40 as an example, soft needle shields, which do not have a hard plastic outer shell, could equally be used in this application with minor changes to account for different geometry.
A further improvement to the device could be a distal end cap 158 (
The RNS removal tool 50 can also have large cut-through arrows 51 indicating the direction of rotation to the end user. It could also have large wings 53 extending radially outward to provide greater rotational mechanical advantage for the end user (see
The RNS removal tool 50, as described above, pulls the RNS 40 off the syringe/needle 24 by radially collapsing at the proximal end of the RNS 40. When the RNS removal tool 50 has completely pulled the RNS 40 off the syringe/needle 24 and the user relaxes their grip, the collapsed capture of the proximal end of the RNS 40 may no longer be present allowing the RNS 40 to unexpectedly separate and fall from the RNS removal tool 50. An improved version of the RNS removal tool 150 is shown in
For those applications where full inspection of the syringe drug contents is required before injection, the main body window 69 shown in
In an alternate embodiment shown in
As the RNS removal tool 50 rotates the axial cam follower 56 will encounter the main body axial cam profile 66 forcing the RNS removal tool 50 to move axially away from the syringe 20. Once the axial cam follower 56 on the RNS removal tool 50 reaches the end of the main body axial cam profile 66 the user will be required to continue to pull the RNS removal tool 50 from the device 10, which will be aided by the needle guard body 80, powered by the spring 61.
As the RNS removal tool 50 is moving axially away from the syringe 20, the RNS removal tool capture lip 75 will be pressed against the barrel of the syringe 20 (
In the foregoing specification, the invention has been described with reference to specific embodiments thereof. It will, however, be evident that various modifications and changes may be made thereto without departing from the broader spirit and scope of the invention. For example, the reader is to understand that the specific ordering and combination of process actions described herein is merely illustrative, unless otherwise stated, and the invention can be performed using different or additional process actions, or a different combination or ordering of process actions. As another example, each feature of one embodiment can be mixed and matched with other features shown in other embodiments. Features and processes known to those of ordinary skill may similarly be incorporated as desired. Additionally and obviously, features may be added or subtracted as desired. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents.
The subject application is a continuation of U.S. application Ser. No. 15/354,311 filed Nov. 17, 2016, which is a continuation of U.S. application Ser. No. 13/290,937 filed Nov. 7, 2011 (now U.S. Pat. No. 9,526,846), which is a continuation-in-part of U.S. application Ser. No. 12/859,698 filed Aug. 19, 2010, which claims the benefit of provisional application Ser. No. 61/235,278 filed Aug. 19, 2009, which applications are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4425120 | Sampson et al. | Jan 1984 | A |
4723943 | Spencer | Feb 1988 | A |
4813940 | Parry | Mar 1989 | A |
4826490 | Byrne et al. | May 1989 | A |
4834717 | Haber et al. | May 1989 | A |
4887998 | Martin | Dec 1989 | A |
4894055 | Sudnak | Jan 1990 | A |
4932940 | Walker et al. | Jun 1990 | A |
4955866 | Corey | Sep 1990 | A |
4976701 | Ejlersen | Dec 1990 | A |
5013305 | Opie et al. | May 1991 | A |
5085639 | Ryan | Feb 1992 | A |
5104384 | Parry | Apr 1992 | A |
5108378 | Firth et al. | Apr 1992 | A |
5195983 | Boese | Mar 1993 | A |
5201708 | Martin | Apr 1993 | A |
5215534 | De Harde et al. | Jun 1993 | A |
5232458 | Chen | Aug 1993 | A |
5242401 | Colsky | Sep 1993 | A |
5269761 | Stehrenberger et al. | Dec 1993 | A |
5338310 | Lewandowski | Aug 1994 | A |
5344405 | Richards | Sep 1994 | A |
5358491 | Johnson et al. | Oct 1994 | A |
5385557 | Thompson | Jan 1995 | A |
5411492 | Sturman et al. | May 1995 | A |
5472430 | Vaillancourt et al. | Dec 1995 | A |
5562624 | Righi et al. | Oct 1996 | A |
5573513 | Wozencroft | Nov 1996 | A |
5582597 | Brimhall et al. | Dec 1996 | A |
5591138 | Vaillancourt | Jan 1997 | A |
5609577 | Haber et al. | Mar 1997 | A |
5634906 | Haber et al. | Jun 1997 | A |
5658259 | Pearson et al. | Aug 1997 | A |
5688241 | Asbaghi | Nov 1997 | A |
5795336 | Romano et al. | Aug 1998 | A |
5833670 | Dillon et al. | Nov 1998 | A |
5843041 | Hake et al. | Dec 1998 | A |
5964731 | Kovelman | Oct 1999 | A |
6077245 | Heinrich et al. | Jun 2000 | A |
6099504 | Gross | Aug 2000 | A |
6110147 | Perouse | Aug 2000 | A |
6186980 | Brunel | Feb 2001 | B1 |
6379336 | Asbaghi et al. | Apr 2002 | B1 |
6524278 | Campbell et al. | Feb 2003 | B1 |
6530905 | Asbaghi | Mar 2003 | B2 |
6537257 | Wien | Mar 2003 | B1 |
6547764 | Larsen et al. | Apr 2003 | B2 |
6565540 | Perouse et al. | May 2003 | B1 |
6648858 | Asbaghi | Nov 2003 | B2 |
6673044 | Righi et al. | Jan 2004 | B2 |
6702784 | Sheckler et al. | Mar 2004 | B1 |
6716199 | DeHarde et al. | Apr 2004 | B2 |
6773415 | Heiniger | Aug 2004 | B2 |
6800066 | Targell | Oct 2004 | B2 |
6846302 | Shemesh et al. | Jan 2005 | B2 |
6869415 | Asbaghi | Mar 2005 | B2 |
6884237 | Asbaghi | Apr 2005 | B2 |
6939330 | McConnell-Montalvo et al. | Sep 2005 | B1 |
6958055 | Donnan et al. | Oct 2005 | B2 |
7001364 | Farhi | Feb 2006 | B1 |
7300422 | Jouvin | Nov 2007 | B2 |
7540858 | DiBiasi | Jun 2009 | B2 |
7666164 | Giambattista et al. | Feb 2010 | B2 |
7699813 | Liversidge | Apr 2010 | B2 |
7875006 | Pessin | Jan 2011 | B2 |
8357125 | Grunhut et al. | Jan 2013 | B2 |
9526846 | Dowds | Dec 2016 | B2 |
10314985 | Dowds | Jun 2019 | B2 |
20010031949 | Asbaghi | Oct 2001 | A1 |
20020004648 | Larsen et al. | Jan 2002 | A1 |
20020004652 | Asbaghi | Jan 2002 | A1 |
20020103461 | Asbaghi | Aug 2002 | A1 |
20020173816 | Hung | Nov 2002 | A1 |
20020193747 | Denolly | Dec 2002 | A1 |
20030028171 | DeHarde et al. | Feb 2003 | A1 |
20030120218 | Asbaghi | Jun 2003 | A1 |
20030139705 | Larsen et al. | Jul 2003 | A1 |
20040087875 | Asbaghi | May 2004 | A1 |
20040111064 | Asbaghi | Jun 2004 | A1 |
20040236283 | Tang | Nov 2004 | A1 |
20050038391 | Wittland | Feb 2005 | A1 |
20050070854 | Wright | Mar 2005 | A1 |
20050096598 | Crawford et al. | May 2005 | A1 |
20050113750 | Targell | May 2005 | A1 |
20050171485 | Larsen et al. | Aug 2005 | A1 |
20050267410 | Koska | Dec 2005 | A1 |
20050277893 | Liversidge | Dec 2005 | A1 |
20060189933 | Alheidt et al. | Aug 2006 | A1 |
20060264825 | Westbye et al. | Nov 2006 | A1 |
20060270984 | Hommann | Nov 2006 | A1 |
20070066936 | Lam | Mar 2007 | A1 |
20070073224 | Dries | Mar 2007 | A1 |
20070129674 | Liversidge | Jun 2007 | A1 |
20070129686 | Daily et al. | Jun 2007 | A1 |
20070129722 | Cosmescu | Jun 2007 | A1 |
20070151942 | Dishongh et al. | Jul 2007 | A1 |
20070156101 | Liversidge | Jul 2007 | A1 |
20070173772 | Liversidge | Jul 2007 | A1 |
20070270759 | Pessin | Nov 2007 | A1 |
20070287964 | Asbaghi | Dec 2007 | A1 |
20080103453 | Liversidge | May 2008 | A1 |
20080167624 | Weston et al. | Jul 2008 | A1 |
20080200881 | Emmott et al. | Aug 2008 | A1 |
20080300546 | Godara et al. | Dec 2008 | A1 |
20090005742 | Liversidge | Jan 2009 | A1 |
20090012478 | Weston | Jan 2009 | A1 |
20090105663 | Brand et al. | Apr 2009 | A1 |
20090204076 | Liversidge | Aug 2009 | A1 |
20090227956 | Emmott et al. | Sep 2009 | A1 |
20090326477 | Liversidge | Dec 2009 | A1 |
20100016803 | Liversidge | Jan 2010 | A1 |
20100036325 | Liversidge | Feb 2010 | A1 |
20100063454 | Liversidge | Mar 2010 | A1 |
20100076382 | Weston | Mar 2010 | A1 |
20100152670 | Low | Jun 2010 | A1 |
20100160869 | Liversidge | Jun 2010 | A1 |
20110098656 | Burnell et al. | Apr 2011 | A1 |
20110319833 | Chun | Dec 2011 | A1 |
Number | Date | Country |
---|---|---|
10009484 | Oct 2001 | DE |
202004016791 | Dec 2004 | DE |
10339794 | Apr 2005 | DE |
102006041128 | Mar 2008 | DE |
102006041809 | Mar 2008 | DE |
0449907 | Oct 1991 | EP |
0559753 | Sep 1993 | EP |
0575492 | Dec 1993 | EP |
0813882 | Dec 1997 | EP |
0824923 | Feb 1998 | EP |
0864335 | Sep 1998 | EP |
1019123 | Jul 2000 | EP |
1032446 | Sep 2000 | EP |
1079878 | Mar 2001 | EP |
1128861 | Sep 2001 | EP |
1284769 | Feb 2003 | EP |
1285674 | Feb 2003 | EP |
1385564 | Feb 2004 | EP |
1452197 | Sep 2004 | EP |
1464352 | Oct 2004 | EP |
1473051 | Nov 2004 | EP |
1483004 | Dec 2004 | EP |
1485153 | Dec 2004 | EP |
1506740 | Feb 2005 | EP |
1605997 | Dec 2005 | EP |
1654020 | May 2006 | EP |
1660158 | May 2006 | EP |
1682206 | Jul 2006 | EP |
1755710 | Feb 2007 | EP |
1762261 | Mar 2007 | EP |
1814612 | Aug 2007 | EP |
1850894 | Nov 2007 | EP |
1949928 | Jul 2008 | EP |
1970086 | Sep 2008 | EP |
2022523 | Feb 2009 | EP |
2414398 | Feb 2012 | EP |
2930160 | Oct 2015 | EP |
2930161 | Oct 2015 | EP |
2930162 | Oct 2015 | EP |
2001521792 | Nov 2001 | JP |
2003511106 | Mar 2003 | JP |
2004504891 | Feb 2004 | JP |
2005520602 | Jul 2005 | JP |
2008246190 | Oct 2008 | JP |
2009509605 | Mar 2009 | JP |
2010540058 | Dec 2010 | JP |
0749758 | Apr 2003 | SI |
1928523 | Nov 2010 | SI |
8204293 | Dec 1982 | WO |
9111212 | Aug 1991 | WO |
9116993 | Nov 1991 | WO |
9605879 | Feb 1996 | WO |
9720538 | Jun 1997 | WO |
0006221 | Feb 2000 | WO |
0013727 | Mar 2000 | WO |
0027450 | May 2000 | WO |
0053244 | Sep 2000 | WO |
0108740 | Feb 2001 | WO |
0132253 | May 2001 | WO |
0142104 | Jun 2001 | WO |
0195805 | Dec 2001 | WO |
02074369 | Sep 2002 | WO |
02087669 | Nov 2002 | WO |
02089878 | Nov 2002 | WO |
02092160 | Nov 2002 | WO |
03105935 | Dec 2003 | WO |
2004028599 | Apr 2004 | WO |
2004028600 | Apr 2004 | WO |
2004041121 | May 2004 | WO |
2004052424 | Jun 2004 | WO |
2004096326 | Nov 2004 | WO |
2004101036 | Nov 2004 | WO |
2004105842 | Dec 2004 | WO |
2005004958 | Jan 2005 | WO |
2005011777 | Feb 2005 | WO |
2005030303 | Apr 2005 | WO |
2005051466 | Jun 2005 | WO |
2005079889 | Sep 2005 | WO |
2007077463 | Jul 2007 | WO |
2007099367 | Sep 2007 | WO |
2007143725 | Dec 2007 | WO |
2008034743 | Mar 2008 | WO |
2008035122 | Mar 2008 | WO |
2008044067 | Apr 2008 | WO |
2008050158 | May 2008 | WO |
2008075080 | Jun 2008 | WO |
2008111931 | Sep 2008 | WO |
2008127195 | Oct 2008 | WO |
2009040602 | Apr 2009 | WO |
2009040672 | Apr 2009 | WO |
2009095701 | Aug 2009 | WO |
2009102720 | Aug 2009 | WO |
2009114762 | Sep 2009 | WO |
2009114777 | Sep 2009 | WO |
2009144549 | Dec 2009 | WO |
Number | Date | Country | |
---|---|---|---|
20190255258 A1 | Aug 2019 | US |
Number | Date | Country | |
---|---|---|---|
61235278 | Aug 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15354311 | Nov 2016 | US |
Child | 16401557 | US | |
Parent | 13290937 | Nov 2011 | US |
Child | 15354311 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 12859698 | Aug 2010 | US |
Child | 13290937 | US |